Refine your search
Availability
-
Authors
-
Topics
- Adalimumab
- Adult
- Aged
- Aged, 80 and over
- Anti-Allergic Agents
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Cost of Illness
- Disability Evaluation
- Female
- Humans
- Male
- Managed Care Programs
- Middle Aged
- Treatment Outcome
- United States
- drug therapy
- therapeutic use
- Show more
- Show less
-
Languages